Literature DB >> 28776267

Outcomes of patients with periprocedural atrial fibrillation undergoing percutaneous coronary intervention for chronic total occlusion.

Barbara E Stähli1, Cathérine Gebhard2, Michael Gick2, Kambis Mashayekhi2, Miroslaw Ferenc2, Heinz Joachim Buettner2, Franz-Josef Neumann2, Aurel Toma3.   

Abstract

BACKGROUND: Successful CTO recanalization has been associated with clinical benefit. Outcomes of patients with atrial fibrillation undergoing CTO PCI have not been investigated, yet. AIMS: This study sought to evaluate the association between atrial fibrillation and outcomes after percutaneous coronary intervention (PCI) for chronic total occlusions (CTO).
METHODS: Consecutive patients undergoing CTO PCI between January 2005 and December 2013 were divided into patients with and without atrial fibrillation, and propensity-matched models used to adjust for baseline differences between groups. The primary outcome was all-cause mortality at a median follow-up of 3.2 (interquartile range 3.1-4.5) years.
RESULTS: Of 2002 patients undergoing CTO PCI, atrial fibrillation was present in 169 (8.4%) patients. Patients with atrial fibrillation were older, and more frequently had hypertension, left ventricular systolic dysfunction, and chronic kidney disease. Before matching, all-cause mortality was 39.6 and 14.5% in the atrial fibrillation and the sinus rhythm groups (HR 2.92, 95% CI 2.23-3.82, p < 0.001). In the propensity-matched model, atrial fibrillation remained associated with an increased risk of mortality (HR 1.62, 95% CI 1.06-2.47, p = 0.03). In the unmatched patient cohort, all-cause mortality was significantly reduced in patients with procedural success, both in the atrial fibrillation (34.9 versus 55.0%, adjusted HR 0.99, 95% CI 0.97-1.00, p = 0.02) and the sinus rhythm groups (12.8 versus 23.0%, adjusted HR 0.70, 95% CI 0.53-0.92, p = 0.01).
CONCLUSIONS: Although atrial fibrillation is independently associated with mortality after CTO PCI, substantial survival benefit of successful CTO recanalization is observed in both patients with and without atrial fibrillation.

Entities:  

Keywords:  Atrial fibrillation; Chronic total occlusion; Percutaneous coronary intervention

Mesh:

Year:  2017        PMID: 28776267     DOI: 10.1007/s00392-017-1148-4

Source DB:  PubMed          Journal:  Clin Res Cardiol        ISSN: 1861-0684            Impact factor:   5.460


  28 in total

1.  Acute myocardial infarction complicated by atrial fibrillation in the elderly: prevalence and outcomes.

Authors:  S S Rathore; A K Berger; K P Weinfurt; K A Schulman; W J Oetgen; B J Gersh; A J Solomon
Journal:  Circulation       Date:  2000-03-07       Impact factor: 29.690

Review 2.  Recanalisation of chronic total coronary occlusions: 2012 consensus document from the EuroCTO club.

Authors:  Georgios Sianos; Gerald S Werner; Alfredo R Galassi; Michail I Papafaklis; Javier Escaned; David Hildick-Smith; Evald Høj Christiansen; Anthony Gershlick; Mauro Carlino; Angelos Karlas; Nikolaos V Konstantinidis; Salvatore D Tomasello; Carlo Di Mario; Nicolaus Reifart
Journal:  EuroIntervention       Date:  2012-05-15       Impact factor: 6.534

3.  Comparison of five-year outcome of sirolimus-eluting stent implantation for chronic total occlusions versus for non-chronic total occlusion (from the j-Cypher registry).

Authors:  Masafumi Kato; Takeshi Kimura; Takeshi Morimoto; Hideo Nishikawa; Fumiya Uchida; Hiroyuki Suzuki; Yasuhiko Hayashi; Kazushige Kadota; Kazuaki Mitsudo
Journal:  Am J Cardiol       Date:  2012-07-25       Impact factor: 2.778

Review 4.  Meta-analysis on the impact of percutaneous coronary intervention of chronic total occlusions on left ventricular function and clinical outcome.

Authors:  Loes P Hoebers; Bimmer E Claessen; Joelle Elias; George D Dangas; Roxana Mehran; José P S Henriques
Journal:  Int J Cardiol       Date:  2015-03-17       Impact factor: 4.164

5.  The significance of new onset atrial fibrillation complicating acute myocardial infarction.

Authors:  Oren Zusman; Guy Amit; Harel Gilutz; Doron Zahger
Journal:  Clin Res Cardiol       Date:  2011-09-11       Impact factor: 5.460

6.  Digoxin and reduction in mortality and hospitalization in heart failure: a comprehensive post hoc analysis of the DIG trial.

Authors:  Ali Ahmed; Michael W Rich; Thomas E Love; Donald M Lloyd-Jones; Inmaculada B Aban; Wilson S Colucci; Kirkwood F Adams; Mihai Gheorghiade
Journal:  Eur Heart J       Date:  2005-12-08       Impact factor: 29.983

7.  Long-term mortality of patients with atrial fibrillation undergoing percutaneous coronary intervention with stent implantation for acute and stable coronary artery disease.

Authors:  Miklos Rohla; Christoph Kleine Vennekate; Ioannis Tentzeris; Matthias K Freynhofer; Serdar Farhan; Florian Egger; Thomas W Weiss; Johann Wojta; Christopher B Granger; Kurt Huber
Journal:  Int J Cardiol       Date:  2015-02-10       Impact factor: 4.164

8.  Outcomes of Patients With Atrial Fibrillation Undergoing Percutaneous Coronary Intervention.

Authors:  Nadia R Sutton; Milan Seth; Cyril Ruwende; Hitinder S Gurm
Journal:  J Am Coll Cardiol       Date:  2016-08-30       Impact factor: 24.094

9.  Antithrombotic therapy and outcomes of patients with atrial fibrillation following primary percutaneous coronary intervention: results from the APEX-AMI trial.

Authors:  Renato D Lopes; Laine E Elliott; Harvey D White; Judith S Hochman; Frans Van de Werf; Diego Ardissino; Torsten T Nielsen; W Douglas Weaver; Petr Widimsky; Paul W Armstrong; Christopher B Granger
Journal:  Eur Heart J       Date:  2009-06-06       Impact factor: 29.983

10.  All-cause mortality in 272,186 patients hospitalized with incident atrial fibrillation 1995-2008: a Swedish nationwide long-term case-control study.

Authors:  Tommy Andersson; Anders Magnuson; Ing-Liss Bryngelsson; Ole Frøbert; Karin M Henriksson; Nils Edvardsson; Dritan Poçi
Journal:  Eur Heart J       Date:  2013-01-14       Impact factor: 29.983

View more
  3 in total

1.  Temporal changes in outcomes of women and men undergoing percutaneous coronary intervention for chronic total occlusion: 2005-2013.

Authors:  Aurel Toma; Barbara E Stähli; Michael Gick; Miroslaw Ferenc; Kambis Mashayekhi; Heinz Joachim Buettner; Franz-Josef Neumann; Catherine Gebhard
Journal:  Clin Res Cardiol       Date:  2018-01-22       Impact factor: 5.460

2.  Symmetric dimethylarginine (SDMA) outperforms asymmetric dimethylarginine (ADMA) and other methylarginines as predictor of renal and cardiovascular outcome in non-dialysis chronic kidney disease.

Authors:  Insa E Emrich; Adam M Zawada; Jens Martens-Lobenhoffer; Danilo Fliser; Stefan Wagenpfeil; Gunnar H Heine; Stefanie M Bode-Böger
Journal:  Clin Res Cardiol       Date:  2017-11-03       Impact factor: 5.460

3.  Reduced Left Ventricular Ejection Fraction Is a Risk Factor for In-Hospital Mortality in Patients after Percutaneous Coronary Intervention: A Hospital-Based Survey.

Authors:  Ziliang Ye; Haili Lu; Lang Li
Journal:  Biomed Res Int       Date:  2018-12-05       Impact factor: 3.411

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.